NewSquare Capital LLC Has $4.26 Million Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

NewSquare Capital LLC lessened its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 213,214 shares of the real estate investment trust’s stock after selling 1,860 shares during the period. NewSquare Capital LLC’s holdings in Healthpeak Properties were worth $4,256,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Avior Wealth Management LLC acquired a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $37,000. Wiser Advisor Group LLC acquired a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $42,000. Continuum Advisory LLC acquired a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $44,000. Finally, AdvisorNet Financial Inc raised its holdings in shares of Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after acquiring an additional 563 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on DOC shares. Scotiabank lowered their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a report on Friday, February 28th. Wells Fargo & Company decreased their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Robert W. Baird decreased their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Mizuho decreased their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Finally, Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and an average target price of $23.92.

Healthpeak Properties Trading Down 0.5 %

Shares of DOC stock opened at $20.30 on Wednesday. The company has a 50 day moving average of $20.19 and a 200-day moving average of $21.32. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12-month low of $16.66 and a 12-month high of $23.26. The firm has a market cap of $14.20 billion, a P/E ratio of 57.99, a PEG ratio of 2.17 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were issued a $0.305 dividend. The ex-dividend date was Friday, February 14th. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.01%. Healthpeak Properties’s dividend payout ratio (DPR) is 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.